CIBC World Market
BBH icon

CIBC World Market’s VanEck Biotech ETF BBH Stock Holding History

CIBC World Market’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,112
Closed -$209K – 1553
2026
Q1 		$209K Sell
1,112
-64
-5% -$12.3K ﹤0.01% 1387
2025
Q4 		$223K Sell
1,176
-53
-4% -$9.81K ﹤0.01% 1351
2025
Q3 		$204K Buy
+1,229
New +$200K ﹤0.01% 1346
2025
Q2 		– Sell
-1,289
Closed -$203K – 1369
2025
Q1 		$203K Sell
1,289
-105
-8% -$17K ﹤0.01% 1266
2024
Q4 		$219K Sell
1,394
-120
-8% -$20.2K ﹤0.01% 1274
2024
Q3 		$269K Hold
1,514
– – ﹤0.01% 1164
2024
Q2 		$255K Sell
1,514
-5
-0.3% -$818 ﹤0.01% 1139
2024
Q1 		$253K Sell
1,519
-80
-5% -$13.2K ﹤0.01% 1162
2023
Q4 		$264K Sell
1,599
-39
-2% -$6K ﹤0.01% 1100
2023
Q3 		$255K Sell
1,638
-76
-4% -$12.1K ﹤0.01% 1066
2023
Q2 		$267K Sell
1,714
-150
-8% -$24K ﹤0.01% 1072
2023
Q1 		$302K Sell
1,864
-80
-4% -$12.9K ﹤0.01% 1045
2022
Q4 		$311K Buy
1,944
+130
+7% +$20.6K ﹤0.01% 1049
2022
Q3 		$255K Buy
1,814
+300
+20% +$45.4K ﹤0.01% 1061
2022
Q2 		$221K Sell
1,514
-271
-15% -$40.4K ﹤0.01% 1120
2022
Q1 		$289K Hold
1,785
– – ﹤0.01% 1099
2021
Q4 		$338K Sell
1,785
-2
-0.1% -$386 ﹤0.01% 1095
2021
Q3 		$361K Buy
1,787
+42
+2% +$8.82K ﹤0.01% 1078
2021
Q2 		$352K Buy
1,745
+50
+3% +$9.31K ﹤0.01% 1100
2021
Q1 		$297K Sell
1,695
-50
-3% -$9.04K ﹤0.01% 1097
2020
Q4 		$296K Sell
1,745
-129
-7% -$21.3K ﹤0.01% 1088
2020
Q3 		$304K Sell
1,874
-9,511
-84% -$1.55M ﹤0.01% 958
2020
Q2 		$1.85M Buy
11,385
+9,552
+521% +$1.45M 0.01% 499
2020
Q1 		$235K Buy
+1,833
New +$247K ﹤0.01% 871
2019
Q2 		– Sell
-1,618
Closed -$208K – 1129
2019
Q1 		$208K Buy
+1,618
New +$204K ﹤0.01% 1081
2014
Q4 		– Sell
-3,356
Closed -$355K – 818
2014
Q3 		$355K Buy
3,356
+55
+2% +$5.57K ﹤0.01% 616
2014
Q2 		$315K Buy
3,301
+145
+5% +$13K ﹤0.01% 610
2014
Q1 		$287K Buy
3,156
+455
+17% +$44.2K ﹤0.01% 633
2013
Q4 		$239K Buy
+2,701
New +$226K ﹤0.01% 622

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CIBC World Market's BBH Position: Q2 2026 in Review

CIBC World Market sold out of VanEck Biotech ETF (BBH) in Q2 2026, closing a stake of 1,112 shares — an estimated $209K sold.

CIBC World Market first reported a position in BBH in Q4 2013 and held it in 29 quarters. The position peaked at $1.85M in Q2 2020. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

  • CIBC World Market reported no remaining VanEck Biotech ETF position as of Q2 2026 after selling out during the quarter.
  • CIBC World Market sold 1,112 VanEck Biotech ETF shares in Q2 2026, an estimated $209K.
  • CIBC World Market first reported a position in VanEck Biotech ETF in Q4 2013 and held it in 29 quarters.
  • CIBC World Market's VanEck Biotech ETF position peaked at $1.85M in Q2 2020.
  • 110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.